Ask AI
neoCARHP
neoCARHP: Phase III Trial of De-escalated Neoadjuvant Taxane + Trastuzumab and Pertuzumab ± Carboplatin in HER2+ EBC

Released: June 10, 2025

Expiration: December 09, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 10, 2025

Expiration: December 09, 2025